Shedding light on the cancer cell death mechanism in photodynamic therapy
Open Access
- 11 October 2026
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 31 (11) , 246
Abstract
Photodynamic therapy (PDT) employs the interaction of a photosensitizer, light, and molecular oxygen to generate reactive oxygen species, which induce regulated cell death pathways that contribute to tumor eradication and immune modulation. Despite its clinical utility, the determinants of tumor selectivity remain incompletely understood. Current evidence suggests that PDT selectivity does not arise from a single mechanism but rather from the dynamic interplay among photosensitizer properties, tumor architecture, microenvironmental heterogeneity, and host immune responses. Here, we integrate current mechanistic understanding of PDT-induced cell death and discuss how tumor-specific factors, including enhanced permeability and retention, differential transporter expression, and microenvironmental heterogeneity, modulate photosensitizer accumulation. We further examine how photosensitizer subcellular localization, tumor biology, and immune microenvironment shape therapeutic outcomes. This integrated perspective highlights opportunities to guide the selection and optimization of PDT agents and treatment strategies toward improved selectivity and immunogenicity, while reinforcing PDT as a versatile modality within modern cancer therapy. Graphical abstractKeywords
Funding Information
- Fonds De La Recherche Scientifique - FNRS (FC 46825)
- Fonds De La Recherche Scientifique - FNRS (FC 51543)
- Fonds De La Recherche Scientifique - FNRS (T.0003.25)
This publication has 254 references indexed in Scilit:
- Leveraging Tumor Microenvironment to Boost Synergistic Photodynamic Therapy, Ferroptosis Anti‐Tumor Efficiency Based on a Functional Iridium(III) ComplexAdvanced Science, 2025
- Bioinspired Nano‐Photosensitizer‐Activated Caspase‐3/GSDME Pathway Induces Pyroptosis in Lung Cancer CellsAdvanced Healthcare Materials, 2024
- Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell DeathAdvanced Functional Materials, 2024
- Cell Membrane‐Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis‐Enhanced Photodynamic ImmunotherapyAdvanced Healthcare Materials, 2024
- Reversing Resistance of Cancer Stem Cells and Enhancing Photodynamic Therapy Based on Hyaluronic Acid Nanomicelles for Preventing Cancer Recurrence and MetastasisAdvanced Healthcare Materials, 2023
- Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage ReprogrammingAdvanced Materials, 2023
- Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring PhotosensitizerAdvanced Science, 2022
- Activation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell AblationAngewandte Chemie, 2021
- Activatable Photosensitizers: Agents for Selective Photodynamic TherapyAdvanced Functional Materials, 2016
- Intracellular Localization of Photosensitizers2007